嘉裏物流聯網(00636.HK)收購康復設備供應商普康
嘉裏物流聯網(00636.HK)宣佈,收購香港康復設備供應商普康醫學儀器有限公司(普康)多數股權。
嘉裏物流聯網將運用旗下嘉裏醫療及嘉裏醫藥的資源,以支援普康在康復設備業於客戶羣、物流及品牌方面的發展。
在普康加入其產品組合後,嘉裏物流聯網將可透過建立於復康行業的專門業務,進一步發展多元化產品,以及拓展其產品至服務業以及予消費者自用,支援居家安老,並擴大其向香港醫院及院舍銷售的產品種類。目前,嘉裏醫療的專長在於心血管、外科及醫療消耗品。嘉裏物流聯網未來將爲普康供應的產品提供物流服務,當中涵蓋儀器進口的國際貨運及於香港和澳門的綜合物流服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.